Ultragenyx Pharmaceutical
RARE
#4012
Rank
โ‚น313.82 B
Marketcap
โ‚น3,186
Share price
3.37%
Change (1 day)
-5.79%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: โ‚น313.82 Billion

As of July 2026 Ultragenyx Pharmaceutical has a market cap of โ‚น313.82 Billion. This makes Ultragenyx Pharmaceutical the world's 4012th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น313.82 B5.98%
2025โ‚น296.11 B-13.91%
2024โ‚น343.96 B5.22%
2023โ‚น326.89 B21.63%
2022โ‚น268.77 B-37%
2021โ‚น426.62 B-36.3%
2020โ‚น669.75 B280.2%
2019โ‚น176.15 B13.92%
2018โ‚น154.62 B22.6%
2017โ‚น126.12 B-35.4%
2016โ‚น195.22 B-32.65%
2015โ‚น289.86 B226.38%
2014โ‚น88.81 B

End of Day market cap according to different sources

On Jul 4th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

โ‚น313.82 Billion
by Nasdaq info icon info icon
โ‚น313.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
โ‚น98.10 B-68.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น77.52 B-75.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น433.14 B 38.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.085 T 245.88%๐Ÿ‡บ๐Ÿ‡ธ USA